{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,4]],"date-time":"2026-04-04T12:19:57Z","timestamp":1775305197366,"version":"3.50.1"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2015,1,7]],"date-time":"2015-01-07T00:00:00Z","timestamp":1420588800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurol Sci"],"published-print":{"date-parts":[[2015,6]]},"DOI":"10.1007\/s10072-014-2052-6","type":"journal-article","created":{"date-parts":[[2015,1,6]],"date-time":"2015-01-06T15:09:37Z","timestamp":1420556977000},"page":"945-951","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["Association of MTHFR C677T with total homocysteine plasma levels and susceptibility to Parkinson\u2019s disease: a meta-analysis"],"prefix":"10.1007","volume":"36","author":[{"given":"Ying","family":"Zhu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rui-Xia","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhi-Yi","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"He-Nan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,1,7]]},"reference":[{"issue":"5","key":"2052_CR1","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1212\/01.WNL.0000137886.74175.5A","volume":"63","author":"RB Postuma","year":"2004","unstructured":"Postuma RB, Lang AE (2004) Homocysteine and levodopa: should Parkinson disease patients receive preventative therapy? Neurology 63(5):886\u2013891","journal-title":"Neurology"},{"issue":"6","key":"2052_CR2","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/S1474-4422(06)70471-9","volume":"5","author":"LM Lau de","year":"2006","unstructured":"de Lau LM, Breteler MM (2006) Epidemiology of Parkinson\u2019s disease. Lancet Neurol 5(6):525\u2013535","journal-title":"Lancet Neurol"},{"issue":"3","key":"2052_CR3","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1212\/WNL.55.3.437","volume":"55","author":"K Yasui","year":"2000","unstructured":"Yasui K, Kowa H, Nakaso K, Takeshima T, Nakashima K (2000) Plasma homocysteine and MTHFR C677T genotype in levodopa-treated patients with PD. Neurology 55(3):437\u2013439","journal-title":"Neurology"},{"issue":"1","key":"2052_CR4","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1046\/j.0022-3042.2001.00676.x","volume":"80","author":"W Duan","year":"2002","unstructured":"Duan W, Ladenheim B, Cutler RG, Kruman II, Cadet JL, Mattson MP (2002) Dietary folate deficiency and elevated homocysteine levels endanger dopaminergic neurons in models of Parkinson\u2019s disease. J Neurochem 80(1):101\u2013110","journal-title":"J Neurochem"},{"issue":"10","key":"2052_CR5","doi-asserted-by":"crossref","first-page":"1918","DOI":"10.1681\/ASN.V11101918","volume":"11","author":"M F\u00f6dinger","year":"2000","unstructured":"F\u00f6dinger M, Buchmayer H, Heinz G, Papagiannopoulos M, Kletzmayr J, Rasoul-Rockenschaub S, H\u00f6rl WH, Sunder-Plassmann G (2000) Effect of MTHFR 1298A\u00a0\u2192\u00a0C and MTHFR 677C\u00a0\u2192\u00a0T genotypes on total homocysteine, folate, and vitamin B(12) plasma concentrations in kidney graft recipients. J Am Soc Nephrol 11(10):1918\u20131925","journal-title":"J Am Soc Nephrol"},{"issue":"3","key":"2052_CR6","first-page":"272","volume":"43","author":"M Bia\u0142ecka","year":"2009","unstructured":"Bia\u0142ecka M, Robowski P, Honczarenko K, Roszmann A, S\u0142awek J (2009) Genetic and environmental factors for hyperhomocysteinaemia and its clinical implications in Parkinson\u2019s disease. Neurol Neurochir Pol 43(3):272\u2013285","journal-title":"Neurol Neurochir Pol"},{"issue":"10","key":"2052_CR7","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1097\/FPC.0b013e32835693f7","volume":"22","author":"M Bia\u0142ecka","year":"2012","unstructured":"Bia\u0142ecka M, Kurzawski M, Roszmann A, Robowski P, Sitek EJ, Honczarenko K, Gorzkowska A, Budrewicz S, Mak M, Jarosz M, Go\u0142\u0105b-Janowska M, Koziorowska-Gawron E, Dro\u017adzik M, S\u0142awek J (2012) Association of COMT, MTHFR, and SLC19A1(RFC-1) polymorphisms with homocysteine blood levels and cognitive impairment in Parkinson\u2019s disease. Pharmacogenet Genomics 22(10):716\u2013724. doi: 10.1097\/FPC.0b013e32835693f7","journal-title":"Pharmacogenet Genomics"},{"issue":"1","key":"2052_CR8","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1007\/s12017-012-8174-1","volume":"14","author":"G Gorgone","year":"2012","unstructured":"Gorgone G, Curr\u00f2 M, Ferlazzo N, Parisi G, Parnetti L, Belcastro V, Tambasco N, Rossi A, Pisani F, Calabresi P, Ientile R, Caccamo D (2012) Coenzyme Q10, hyperhomocysteinemia and MTHFR C677T polymorphism in levodopa-treated Parkinson\u2019s disease patients. Neuromolecular Med 14(1):84\u201390. doi: 10.1007\/s12017-012-8174-1","journal-title":"Neuromolecular Med"},{"issue":"3\u20134","key":"2052_CR9","first-page":"332","volume":"412","author":"CS Fong","year":"2010","unstructured":"Fong CS, Shyu HY, Shieh JC, Fu YP, Chin TY, Wang HW, Cheng CW (2010) Association of MTHFR, MTR, and MTRR polymorphisms with Parkinson\u2019s disease among ethnic Chinese in Taiwan. Clin Chim Acta 412(3\u20134):332\u2013338. doi: 10.1016\/j.cca.2010.11.004","journal-title":"Clin Chim Acta"},{"issue":"10","key":"2052_CR10","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1002\/mds.22522","volume":"24","author":"MC Rodriguez-Oroz","year":"2009","unstructured":"Rodriguez-Oroz MC, Lage PM, Sanchez-Mut J, Lamet I, Pagonabarraga J, Toledo JB, Garc\u00eda-Garcia D, Clavero P, Samaranch L, Irurzun C, Matsubara JM, Irigoien J, Bescos E, Kulisevsky J, P\u00e9rez-Tur J, Obeso JA (2009) Homocysteine and cognitive impairment in Parkinson\u2019s disease: a biochemical, neuroimaging, and genetic study. Mov Disord 24(10):1437\u20131444. doi: 10.1002\/mds.22522","journal-title":"Mov Disord"},{"issue":"2","key":"2052_CR11","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1002\/mds.22227","volume":"24","author":"RM Camicioli","year":"2009","unstructured":"Camicioli RM, Bouchard TP, Somerville MJ (2009) Homocysteine is not associated with global motor or cognitive measures in nondemented older Parkinson\u2019s disease patients. Mov Disord 24(2):176\u2013182. doi: 10.1002\/mds.22227","journal-title":"Mov Disord"},{"issue":"1\u20132","key":"2052_CR12","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.jns.2009.09.007","volume":"287","author":"RY Yuan","year":"2009","unstructured":"Yuan RY, Sheu JJ, Yu JM, Hu CJ, Tseng IJ, Ho CS, Yeh CY, Hung YL, Chiang TR (2009) Methylenetetrahydrofolate reductase polymorphisms and plasma homocysteine in levodopa-treated and non-treated Parkinson\u2019s disease patients. J Neurol Sci 287(1\u20132):64\u201368. doi: 10.1016\/j.jns.2009.09.007","journal-title":"J Neurol Sci"},{"issue":"3","key":"2052_CR13","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/s12017-007-8006-x","volume":"9","author":"D Caccamo","year":"2007","unstructured":"Caccamo D, Gorgone G, Curr\u00f2 M, Parisi G, Di Iorio W, Menichetti C, Belcastro V, Parnetti L, Rossi A, Pisani F, Ientile R, Calabresi P (2007) Effect of MTHFR polymorphisms on hyperhomocysteinemia in levodopa-treated Parkinsonian patients. Neuromolecular Med 9(3):249\u2013254","journal-title":"Neuromolecular Med"},{"issue":"2","key":"2052_CR14","doi-asserted-by":"crossref","first-page":"113","DOI":"10.55782\/ane-2007-1639","volume":"67","author":"J Dorszewska","year":"2007","unstructured":"Dorszewska J, Florczak J, Rozycka A, Kempisty B, Jaroszewska-Kolecka J, Chojnacka K, Trzeciak WH, Kozubski W (2007) Oxidative DNA damage and level of thiols as related to polymorphisms of MTHFR, MTR, MTHFD1 in Alzheimer\u2019s and Parkinson\u2019s diseases. Acta Neurobiol Exp (Wars) 67(2):113\u2013129","journal-title":"Acta Neurobiol Exp (Wars)"},{"issue":"3","key":"2052_CR15","first-page":"150","volume":"16","author":"JJ Lin","year":"2007","unstructured":"Lin JJ, Yueh KC, Liu CS, Liu JT, Lin SZ (2007) 5,10-methylenetetrahydrofolate reductase C677T gene polymorphism can influence age at onset of Parkinson\u2019s disease. Acta Neurol Taiwan 16(3):150\u2013157","journal-title":"Acta Neurol Taiwan"},{"issue":"1\u20132","key":"2052_CR16","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.neulet.2006.05.040","volume":"404","author":"D Religa","year":"2006","unstructured":"Religa D, Czyzewski K, Styczynska M, Peplonska B, Lokk J, Chodakowska-Zebrowska M, Stepien K, Winblad B, Barcikowska M (2006) Hyperhomocysteinemia and methylenetetrahydrofolate reductase polymorphism in patients with Parkinson\u2019s disease. Neurosci Lett 404(1\u20132):56\u201360","journal-title":"Neurosci Lett"},{"issue":"1\u20132","key":"2052_CR17","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.jns.2006.05.040","volume":"248","author":"Z Todorovi\u0107","year":"2006","unstructured":"Todorovi\u0107 Z, Dzolji\u0107 E, Novakovi\u0107 I, Mirkovi\u0107 D, Stojanovi\u0107 R, Nesi\u0107 Z, Krajinovi\u0107 M, Prostran M, Kosti\u0107 V (2006) Homocysteine serum levels and MTHFR C677T genotype in patients with Parkinson\u2019s disease, with and without levodopa therapy. J Neurol Sci 248(1\u20132):56\u201361","journal-title":"J Neurol Sci"},{"issue":"6","key":"2052_CR18","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1002\/ana.20696","volume":"58","author":"U W\u00fcllner","year":"2005","unstructured":"W\u00fcllner U, K\u00f6lsch H, Linnebank M (2005) Methylenetetrahydrofolate reductase in Parkinson\u2019s disease. Ann Neurol 58(6):972\u2013973","journal-title":"Ann Neurol"},{"issue":"6","key":"2052_CR19","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1002\/ana.20509","volume":"57","author":"LM Lau de","year":"2005","unstructured":"de Lau LM, Koudstaal PJ, van Meurs JB, Uitterlinden AG, Hofman A, Breteler MM (2005) Methylenetetrahydrofolate reductase C677T genotype and PD. Ann Neurol 57(6):927\u2013930","journal-title":"Ann Neurol"},{"issue":"6","key":"2052_CR20","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1136\/jnnp.62.6.671","volume":"62","author":"DL Harmon","year":"1997","unstructured":"Harmon DL, Ramsbottom D, Whitehead AS, Ben-Shlomo Y, Davey-Smith G (1997) The thermolabile variant of 5,10-methylenetetrahydrofolate reductase is not associated with Parkinson\u2019s disease. J Neurol Neurosurg Psychiatry 62(6):671","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"15","key":"2052_CR21","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1001\/jama.283.15.2008","volume":"283","author":"DF Stroup","year":"2000","unstructured":"Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D, Moher D, Becker BJ, Sipe TA, Thacker SB (2000) Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA 283(15):2008\u20132012","journal-title":"JAMA"},{"issue":"4","key":"2052_CR22","first-page":"719","volume":"22","author":"N Mantel","year":"1959","unstructured":"Mantel N, Haenszel W (1959) Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 22(4):719\u2013748","journal-title":"J Natl Cancer Inst"},{"issue":"3","key":"2052_CR23","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","volume":"7","author":"R DerSimonian","year":"1986","unstructured":"DerSimonian R, Laird N (1986) Meta-analysis in clinical trials. Control Clin Trials 7(3):177\u2013188","journal-title":"Control Clin Trials"},{"issue":"4","key":"2052_CR24","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.2307\/2533446","volume":"50","author":"CB Begg","year":"1994","unstructured":"Begg CB, Mazumdar M (1994) Operating characteristics of a rank correlation test for publication bias. Biometrics 50(4):1088\u20131101","journal-title":"Biometrics"},{"issue":"7109","key":"2052_CR25","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","volume":"315","author":"M Egger","year":"1997","unstructured":"Egger M, Davey Smith G, Schneider M, Minder C (1997) Bias in meta-analysis detected by a simple, graphical test. BMJ 315(7109):629\u2013634","journal-title":"BMJ"},{"issue":"3","key":"2052_CR26","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1136\/jnnp.55.3.181","volume":"55","author":"AJ Hughes","year":"1992","unstructured":"Hughes AJ, Daniel SE, Kilford L, Lees AJ (1992) Accuracy of clinical diagnosis of idiopathic Parkinson\u2019s disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry 55(3):181\u2013184","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"12","key":"2052_CR27","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1016\/S1474-4422(10)70256-8","volume":"9","author":"AL Benabid","year":"2010","unstructured":"Benabid AL (2010) Gene therapy for Parkinson\u2019s disease: do we have the cure? Lancet Neurol 9(12):1142\u20131143. doi: 10.1016\/S1474-4422(10)70256-8","journal-title":"Lancet Neurol"},{"issue":"10","key":"2052_CR28","doi-asserted-by":"crossref","first-page":"1852","DOI":"10.1373\/clinchem.2009.125021","volume":"55","author":"R Obeid","year":"2009","unstructured":"Obeid R, Schadt A, Dillmann U, Kostopoulos P, Fassbender K, Herrmann W (2009) Methylation status and neurodegenerative markers in Parkinson disease. Clin Chem 55(10):1852\u20131860. doi: 10.1373\/clinchem.2009.125021","journal-title":"Clin Chem"},{"issue":"13","key":"2052_CR29","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1097\/WNR.0b013e3282aaa0b4","volume":"18","author":"K Imamura","year":"2007","unstructured":"Imamura K, Takeshima T, Nakaso K, Nakashima K (2007) Homocysteine is toxic for dopaminergic neurons in primary mesencephalic culture. NeuroReport 18(13):1319\u20131322","journal-title":"NeuroReport"},{"issue":"1","key":"2052_CR30","doi-asserted-by":"crossref","first-page":"e30","DOI":"10.1111\/ane.12245","volume":"130","author":"Q Liao","year":"2014","unstructured":"Liao Q, Li NN, Mao XY, Chang XL, Zhao DM, Zhang JH, Yu WJ, Tan EK, Peng R (2014) MTHFR C677T variant reduces risk of sporadic Parkinson\u2019s disease in ethnic Chinese. Acta Neurol Scand 130(1):e30\u2013e34. doi: 10.1111\/ane.12245","journal-title":"Acta Neurol Scand"},{"issue":"2","key":"2052_CR31","first-page":"121","volume":"33","author":"N Chao","year":"2014","unstructured":"Chao N, Sun L, Yu HY, Zhao LJ, Zeng XY, Gu WH, Yang Z, Qin B (2014) Association between methylenetetrahydrofolate reductase gene C677T polymorphism and Parkinson\u2019s disease combined with hyperhomocysteinemia. Chin J Geriatr 33(2):121\u2013125. doi: 10.3760\/cma.j.issn.0254-9026.2014.02.003","journal-title":"Chin J Geriatr"},{"issue":"1","key":"2052_CR32","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.gene.2013.07.034","volume":"531","author":"ZG Zhu","year":"2013","unstructured":"Zhu ZG, Ai QL, Wang WM, Xiao ZC (2013) Meta-analysis supports association of a functional SNP (rs1801133) in the MTHFR gene with Parkinson\u2019s disease. Gene 531(1):78\u201383. doi: 10.1016\/j.gene.2013.07.034","journal-title":"Gene"},{"issue":"1\u20132","key":"2052_CR33","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.ymgme.2013.07.012","volume":"110","author":"V Iacobazzi","year":"2013","unstructured":"Iacobazzi V, Castegna A, Infantino V, Andria G (2013) Mitochondrial DNA methylation as a next-generation biomarker and diagnostic tool. Mol Genet Metab 110(1\u20132):25\u201334. doi: 10.1016\/j.ymgme.2013.07.012","journal-title":"Mol Genet Metab"}],"container-title":["Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-014-2052-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10072-014-2052-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-014-2052-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,6]],"date-time":"2024-06-06T10:38:44Z","timestamp":1717670324000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10072-014-2052-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,1,7]]},"references-count":33,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2015,6]]}},"alternative-id":["2052"],"URL":"https:\/\/doi.org\/10.1007\/s10072-014-2052-6","relation":{},"ISSN":["1590-1874","1590-3478"],"issn-type":[{"value":"1590-1874","type":"print"},{"value":"1590-3478","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,1,7]]}}}